It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Help for Hives has been created and funded by Novartis Pharmaceuticals UK Ltd.

Further support 

Please note these links will take you to websites over which Novartis Pharmaceuticals UK Limited has no ownership or control. Novartis Pharmaceuticals UK Limited accepts no responsibility for the content, accuracy, or your use of linked websites. The linked websites may have changed since last accessed in June 2022.

Visit these sites for more information about urticaria and related national and international communities:

Allergy UK


British Skin



British Association of Dermatologists (BAD) Patient Hub 

DermNet NZ

Urticaria Day


Download our
patient guide

We have developed this handy patient guide full of information about CSU and urticaria to help you on your CSU journey.

Download our
CSU infographic

Download this infographic to learn more about the impact of chronic spontaneous urticaria in the UK.

Measure your urticaria impact

Take control of your treatment journey with HiveHelper

To help your doctor find the best treatment for you, it is really important to measure your condition regularly.  HiveHelper is our virtual companion to help you learn more about urticaria and CSU.

HiveHelper is only currently available if you have Facebook Messenger. We are working on another way for those without Facebook to access the virtual companion tool. If you don’t have Facebook, you can download our interactive PDF resources here, which you can use to measure the impact of urticaria and CSU.

Other ways to measure the impact of your hives


Cruse Control App

The CRUSE® app -- ChRonic Urticaria Self Evaluation app -- is another digital tool designed to help patients with chronic urticaria to monitor their condition. Having launched its pilot release in early 2022, the mobile app is developed independently by internationally-leading dermatology and allergy experts from UCARE, with financial support from Novartis (Novartis has no role in app ownership, data management, or control). There will be ongoing releases to expand and optimise use and may be unavailable during updates. Visit the  for the latest information.

Alternatively, we also have three interactive PDFs that can help you to measure the impact of CSU. Regularly completing the online questionnaires that are right for you will give you and your medical team a greater understanding of how CSU is affecting your life and guide which treatment your healthcare professional recommends.

You’re not alone 

If you are diagnosed with CSU, you are not alone; CSU affects millions of people worldwide.1
Take a look below to see what CSU patients Laura and Mark have to say.

We’d love your feedback

UK  |  June 2022  |  204803


  1. Maurer M, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy 2011;66(3):317–330;

UK  |  June 2022  |  196223